67 results
Page 2 of 4
8-K
EX-10.1
vep3s
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
evk b5x3o
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-10.6
5fg7sv69dmaq9srxsp
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-10.3
vbw678p ajw8olw
3 Oct 22
Maravai LifeSciences Announces CEO Leadership Transition
4:07pm
8-K
EX-10.1
tv5rp8juwuikvuerxl6
20 Jan 22
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
zpawq820y0cn3h3brm
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
DEF 14A
vd79a
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
nq25y4b1sqxaxsvb
9 Apr 21
Preliminary proxy
4:16pm
424B4
u4jxjpe ub2
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
6mf5r
25 Mar 21
Draft registration statement
12:00am
8-K
EX-10.9
uxlr ipw1di7
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.8
5vha0mdx5m3fuiywy9
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
9jb89yj6enie dz9bv
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
8-K
EX-10.10
205j5g 6z1ukwjs
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
S-8
EX-10.1
98mn bs6lq0xu
23 Nov 20
Registration of securities for employees
5:06pm